Human papillomavirus and cervical cancer
Clinical Microbiology Reviews, ISSN: 0893-8512, Vol: 16, Issue: 1, Page: 1-17
2003
- 1,405Citations
- 2,049Captures
- 16Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Most Recent News
Conglomerated Imiquimod and Metronidazole Incorporated Biodegradable Nanofibrous Mats for Potential Therapy of Cervical Cancer
Introduction Cervical carcinoma is one of the most common gynecological cancers worldwide, accounting for approximately 12% of all carcinomas in women.1 It originates from abnormal
Review Description
Of the many types of human papillomavirus (HPV), more than 30 infect the genital tract. The association between certain oncogenic (high-risk) strains of HPV and cervical cancer is well established. Although HPV is essential to the transformation of cervical epithelial cells, it is not sufficient, and a variety of cofactors and molecular events influence whether cervical cancer will develop. Early detection and treatment of precancerous lesions can prevent progression to cervical cancer. Identification of precancerous lesions has been primarily by cytologic screening of cervical cells. Cellular abnormalities, however, may be missed or may not be sufficiently distinct, and a portion of patients with borderline or mildly dyskaryotic cytomorphology will have higher-grade disease identified by subsequent colposcopy and biopsy. Sensitive and specific molecular techniques that detect HPV DNA and distinguish high-risk HPV types from low-risk HPV types have been introduced as an adjunct to cytology. Earlier detection of high-risk HPV types may improve triage, treatment, and follow-up in infected patients. Currently, the clearest role for HPV DNA testing is to improve diagnostic accuracy and limit unnecessary colposcopy in patients with borderline or mildly abnormal cytologic test results.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0037243946&origin=inward; http://dx.doi.org/10.1128/cmr.16.1.1-17.2003; http://www.ncbi.nlm.nih.gov/pubmed/12525422; http://cmr.asm.org/cgi/doi/10.1128/CMR.16.1.1-17.2003; https://syndication.highwire.org/content/doi/10.1128/CMR.16.1.1-17.2003; https://journals.asm.org/doi/10.1128/CMR.16.1.1-17.2003; https://dx.doi.org/10.1128/cmr.16.1.1-17.2003; https://cmr.asm.org/content/16/1/1; https://cmr.asm.org/content/16/1/1.abstract; https://cmr.asm.org/content/16/1/1.full.pdf; https://journals.asm.org/doi/abs/10.1128/CMR.16.1.1-17.2003; http://cmr.asm.org/content/16/1/1
American Society for Microbiology
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know